BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9588754)

  • 1. HLA-B27 and the spondylarthropathies in Lebanon: comment on the article by Awada et al.
    Abdelnoor A
    Arthritis Rheum; 1998 May; 41(5):949. PubMed ID: 9588754
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible protective role of HLA-B*2706 for ankylosing spondylitis.
    Ren EC; Koh WH; Sim D; Boey ML; Wee GB; Chan SH
    Tissue Antigens; 1997 Jan; 49(1):67-9. PubMed ID: 9027969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased frequency of HLA-Bw35 CREG antigens in HLA-B27 negative ankylosing spondylitis.
    Wagener P; Zeidler H; Eckert G; Deicher H
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):134-5. PubMed ID: 6606464
    [No Abstract]   [Full Text] [Related]  

  • 4. Ankylosing spondylitis, HLA B27, and beyond.
    Nuki G
    Lancet; 1998 Mar; 351(9105):767-9. PubMed ID: 9519942
    [No Abstract]   [Full Text] [Related]  

  • 5. HLA-B27 and ankylosing spondylitis in the Mexican Mestizo population.
    Arellano J; Vallejo M; Jimenez J; Mintz G; Kretschmer RR
    Tissue Antigens; 1984 Feb; 23(2):112-6. PubMed ID: 6608804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-B associations of HLA-B27 negative ankylosing spondylitis: comment on the article by Yamaguchi et al.
    Brown M; Bunce M; Calin A; Darke C; Wordsworth P
    Arthritis Rheum; 1996 Oct; 39(10):1768-9. PubMed ID: 8843876
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of previously unrecognized predisposing factors for ankylosing spondylitis from analysis of HLA-B27 extended haplotypes in Sardinia.
    Cascino I; Paladini F; Belfiore F; Cauli A; Angelini C; Fiorillo MT; Mathieu A; Sorrentino R
    Arthritis Rheum; 2007 Aug; 56(8):2640-51. PubMed ID: 17665395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis.
    Jaakkola E; Herzberg I; Laiho K; Barnardo MC; Pointon JJ; Kauppi M; Kaarela K; Tuomilehto-Wolf E; Tuomilehto J; Wordsworth BP; Brown MA
    Ann Rheum Dis; 2006 Jun; 65(6):775-80. PubMed ID: 16249228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-B7/B27 constructs: a tool to understand the molecular mimicry hypothesis between HLA-B27 and gram-negative bacterial antigens in ankylosing spondylitis.
    Toubert A; Sire J; Sodoyer R; Amor B; Jordan BR
    Br J Rheumatol; 1988; 27 Suppl 2():19-22. PubMed ID: 3261187
    [No Abstract]   [Full Text] [Related]  

  • 10. HLA-B27 in the Greek Cypriot population: distribution of subtypes in patients with ankylosing spondylitis and other HLA-B27-related diseases. The possible protective role of B*2707.
    Varnavidou-Nicolaidou A; Karpasitou K; Georgiou D; Stylianou G; Kokkofitou A; Michalis C; Constantina C; Gregoriadou C; Kyriakides G
    Hum Immunol; 2004 Dec; 65(12):1451-4. PubMed ID: 15603872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reply to "Association of HLA-B27 and its subtypes with ankylosing spondylitis and clinical manifestations of ankylosing spondylitis in different HLA-B27 subtypes: comment on the article by Lin et al.".
    Lin H; Gong YZ
    Rheumatol Int; 2017 Oct; 37(10):1685. PubMed ID: 28831555
    [No Abstract]   [Full Text] [Related]  

  • 12. [Association of HLA molecules with autoimmune diseases].
    Kolostová K; Cerná M; Andĕl M
    Cas Lek Cesk; 2002 Dec; 141(24):755-62. PubMed ID: 12661465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenetics, HLA-B27 and spondyloarthropathies.
    González S; Martínez-Borra J; López-Larrea C
    Curr Opin Rheumatol; 1999 Jul; 11(4):257-64. PubMed ID: 10411379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Spondylarthritis ankylopoietica and HLA-B27].
    Benevolenskaia LI
    Ter Arkh; 1992; 64(5):106-10. PubMed ID: 1455363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is HLA-B27 the ankylosing spondylitis susceptibility gene?
    Bensen WG; Singal DP
    J Rheumatol; 1985 Oct; 12(5):949-52. PubMed ID: 3878882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular variants of the HLA-B27 antigen in healthy individuals and patients with spondylarthropathies.
    Turek PJ; Grumet FC; Engleman EG
    Immunol Rev; 1985 Aug; 86():71-91. PubMed ID: 2412952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ankylosing spondylitis syndrome in patients without HLA-B27.
    Jajić I; Kerhin V; Kastelan A
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):136. PubMed ID: 6606465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of HLA-B27 subtypes in Iranian patients with ankylosing spondylitis.
    Nicknam MH; Mahmoudi M; Amirzargar AA; Ganjalikhani Hakemi M; Khosravi F; Jamshidi AR; Amirkhani A; Ansaripour B; Pourpak Z; Moin M; Nikbin B
    Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):19-24. PubMed ID: 18322308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More on ankylosing spondylitis and HLA-B27.
    Russell AS
    J Rheumatol; 1986 Aug; 13(4):828-9. PubMed ID: 3490576
    [No Abstract]   [Full Text] [Related]  

  • 20. HLA B27, the arthritogenic peptide, and the effector T cell.
    Calin A
    Lancet; 1993 Sep; 342(8872):629. PubMed ID: 8103139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.